Non-invasive tests for the evaluation of liver fibrosis in MASLD

Nature Medicine · Published 2026-08-03 · DOI 10.1038/s41591-026-04560-x

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41591-026-04560-x

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial · Nature Medicine · 2026 · Same journal
• Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial · Nature Medicine · 2026 · Same journal
• FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial · Nature Medicine · 2026 · Same journal
• Data rights are the missing pillar for modernizing consent in medicine · Nature Medicine · 2026 · Same journal
• Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection · Nature Medicine · 2026 · Same journal
• Multi-omics maps human–pig interactions in extracorporeal liver cross-circulation · Nature Medicine · 2026 · Same journal
• Oligonucleotide–siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trial · Nature Medicine · 2026 · Same journal
• The genetic architecture of fibromyalgia across 2.5 million individuals · Nature Medicine · 2026 · Same journal
• Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy · Nature Medicine · 2026 · Same journal
• Early detection of Alzheimer’s disease with circular RNA from blood · Nature Medicine · 2026 · Same journal